Docetaxel nanoparticle

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDocetaxel nanoparticle

Drug Alias NameMBPY-004

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTubulin inhibitorsMitosis inhibitorsTubulin polymerisation promoters

TargetsTubulin

Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungOvarian NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMebiopharm Co Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsCarcinoma, Non-Small-Cell LungOvarian NeoplasmsBreast Neoplasms

Inactive IndicationsN/A

ATC CodeN/A